Metabolic: Insulin resistance, stubborn weight that wont shift despite diet and training, and unstable glucose readings
Tirzepatide causes thyroid C-cell tumors in rats, and although its unknown whether tirzepatide causes thyroid C-cell tumors in humans, it is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
-
Reading the syringe correctly U-100 insulin syringes come in three common sizes: 30-unit (0.3 mL), 50-unit (0.5 mL), and 100-unit (1.0 mL)
Understanding Metabolic Regulation and Its Influence on Cell Physiology
The STEP trials demonstrated weight reductions of approximately 14.9% on average, and the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major adverse cardiovascular events in overweight and obese non-diabetic patients, transforming obesity into a cardiovascular indication and massively expanding the prescribing universe and reimbursement coverage